British 9.340297
ĠBi 8.530556
otech 2.4669666
Ġplc 6.7176394
's 5.362653
Ġcancer 8.133778
Ġdrug 0.9695978
ĠMar 8.825924
im 2.0001593
ast 1.390748
at 0.00034023033
ĠShows 7.5706234
ĠPromise 0.9900024
, 4.8140326
ĠBut 3.1892657
ĠFaces 6.950087
ĠH 6.320944
urd 0.0019612247
les 0.031792272
Ġto 3.9730783
ĠBecome 4.512425
Ġa 1.5437217
ĠBlock 4.425769
buster 0.0015129582
Ċ 4.558953
British 1.7222202
ĠBi 0.10760166
otech 0.008385854
Ġplc 0.08735366
Ġannounced 6.1727457
Ġpromising 3.7696683
Ġresults 0.95688546
Ġfor 1.8819513
Ġits 0.35711765
Ġcancer 1.3035357
Ġdrug 0.085165545
, 2.200393
ĠMar 0.28781292
im 0.000110576206
ast 0.00036216015
at 0.00031139038
, 0.2691718
Ġwhich 2.7797728
Ġtargets 4.339838
Ġthe 1.3243678
Ġfast 9.770902
-growing 0.23432685
Ġmatrix 12.09795
Ġmetal 0.029731635
lo 0.012763789
protein 0.036743734
ase 0.22618686
Ġ( 1.3133361
M 0.024172405
MP 0.0038563705
) 0.33019057
Ġmarket 8.222541
. 0.6768556
ĠThe 1.1884228
Ġdrug 1.4705529
Ġis 1.7544645
Ġdesigned 2.8942215
Ġto 0.06796499
Ġinhibit 2.8479996
Ġthe 0.7199832
Ġactivity 1.4454806
Ġof 0.008432427
Ġspecific 5.738618
ĠMMP 0.5288713
s 0.30459863
Ġthat 1.8112468
Ġpromote 2.9862132
Ġthe 1.4895514
Ġgrowth 0.82664967
Ġand 1.2124414
Ġspread 0.62820524
Ġof 0.0029532164
Ġcancer 0.826943
Ġcells 0.68902266
. 0.7350131
ĠThe 1.3757266
Ġdrug 1.5048596
Ġis 1.3848763
Ġcurrently 1.5629107
Ġin 0.81731737
ĠPhase 0.6645008
ĠIII 1.4122496
Ġclinical 0.82015574
Ġtrials 0.22336233
, 2.0532057
Ġand 1.0710202
Ġresults 3.1055965
Ġfrom 1.1912949
Ġa 2.2237442
Ġrecent 2.9108963
Ġtrial 2.8040931
Ġdemonstrate 6.1330533
Ġthe 2.1164196
Ġdrug 0.49308068
's 1.0920376
Ġpotential 1.257425
Ġas 2.6595628
Ġa 0.18725607
Ġtherapeutic 4.483569
Ġoption 1.5128269
Ġfor 0.23407929
Ġcancer 3.8903708
Ġpatients 0.274091
.Ċ 4.8225985
Mar 2.041441
im 0.00029255985
ast 0.0004769056
at 0.0007176732
Ġhas 2.426089
Ġbeen 1.5854592
Ġproven 4.876872
Ġto 0.4362294
Ġbe 1.0103643
Ġeffective 1.4731945
Ġagainst 2.0882874
Ġa 1.3415906
Ġwide 1.7244986
Ġrange 0.43435428
Ġof 0.0021181428
Ġcancers 0.93321383
, 0.46524245
Ġincluding 0.3573398
Ġpancreatic 3.5341275
Ġcancer 1.3011919
, 0.21745528
Ġcolore 2.0124907
ctal 0.00074815995
Ġcancer 0.0717239
, 0.17242636
Ġand 1.5321208
Ġmetast 4.3081813
atic 0.013850942
Ġmelan 2.2102573
oma 0.008536562
. 0.38783762
ĠThe 1.3099095
Ġdrug 0.556898
Ġinhib 4.253438
its 0.00026515033
Ġthe 0.6572928
Ġactivity 0.5614023
Ġof 0.008256281
ĠMMP 0.76552296
s 1.1634871
, 1.4096129
Ġwhich 0.6647144
Ġplay 2.7441378
Ġcritical 5.2748966
Ġroles 0.011110308
Ġin 0.02662862
Ġmany 3.3207355
Ġphysiological 5.118312
Ġprocesses 0.49962485
, 0.7198987
Ġsuch 1.9370058
Ġas 0.0020108372
Ġtissue 1.9783086
Ġremodeling 1.4618169
, 0.6605119
Ġwound 2.0355146
Ġhealing 0.08837143
, 0.08198389
Ġand 0.50264466
Ġtumor 2.7091973
Ġinvasion 1.1126691
. 0.60748214
ĠWhen 4.2559447
ĠMMP 1.3714069
s 0.12607673
Ġare 0.17635524
Ġover 2.1670914
activated 3.368243
, 0.19229664
Ġas 6.486275
Ġin 1.0659095
Ġcancer 1.173414
, 0.51968014
Ġthey 0.7456376
Ġpromote 1.708552
Ġthe 0.54471695
Ġgrowth 0.5025175
Ġand 0.4739683
Ġspread 0.07772323
Ġof 0.0015590203
Ġcancer 0.3818941
Ġcells 0.04669319
Ġby 2.0977426
Ġde 2.432962
grading 0.0029566623
Ġthe 1.8481947
Ġextr 0.611904
acellular 0.00028636496
Ġmatrix 0.009994646
Ġ( 1.0647635
EC 0.12029624
M 9.770221e-05
) 0.81949824
Ġsurrounding 2.6536508
Ġthe 0.91053057
Ġtumor 0.9919984
.Ċ 2.1484275
The 1.8467615
ĠPhase 1.9799298
ĠIII 0.19227332
Ġclinical 0.92101675
Ġtrial 0.36753288
Ġconducted 3.4407556
Ġby 0.509292
ĠBritish 1.3711554
ĠBi 0.010719055
otech 0.0020863777
Ġplc 2.9366581
Ġdemonstrated 3.374868
Ġthat 0.8314381
ĠMar 0.3176147
im 1.6524515e-05
ast 0.0003840789
at 0.00038682064
Ġcan 2.8925622
Ġsignificantly 1.9189883
Ġimprove 1.9077233
Ġthe 0.9258639
Ġprogression 3.1433685
-free 0.094819546
Ġsurvival 0.066120125
Ġrate 2.123317
Ġof 1.0756476
Ġpatients 0.46581048
Ġwith 0.17631257
Ġadvanced 1.2048087
Ġpancreatic 1.7683413
Ġcancer 0.09631742
. 0.88159806
ĠIn 2.232538
Ġthe 0.8826534
Ġtrial 0.9132369
, 0.028825631
Ġpatients 1.2208072
Ġwho 1.6147002
Ġreceived 0.41364118
ĠMar 0.3359781
im 0.00011415232
ast 0.00041351124
at 0.0006034302
Ġhad 1.7134669
Ġa 0.49573535
Ġmedian 0.9537032
Ġprogression 0.2858602
-free 0.0411652
Ġsurvival 0.003581657
Ġrate 1.9350264
Ġof 0.055692736
Ġ 0.12000986
2 4.066263
. 0.038191248
3 2.3737602
Ġmonths 0.042279303
, 0.7930628
Ġcompared 0.57689714
Ġto 0.3015871
Ġ 0.480694
1 0.64354044
. 0.008348258
6 2.1455019
Ġmonths 0.008929139
Ġfor 0.54106885
Ġpatients 0.638864
Ġwho 0.34953937
Ġreceived 0.4056894
Ġthe 2.5882547
Ġplacebo 1.217588
. 0.39725497
ĠThe 1.3032967
Ġdrug 1.9314113
Ġshowed 4.1947265
Ġsimilar 2.6346729
Ġpromising 6.303646
Ġresults 0.13882607
Ġin 0.5798683
Ġthe 2.0816238
Ġtreatment 2.6719015
Ġof 0.0046363687
Ġother 4.1005535
Ġcancers 0.9292312
Ġas 2.4966142
Ġwell 0.009606034
.Ċ 1.4693689
However 2.1602411
, 0.001188326
Ġdespite 3.4716933
ĠMar 2.5322306
im 0.00010735771
ast 0.000508115
at 0.0011044947
's 0.0915916
Ġpotential 2.2423105
Ġto 1.5269129
Ġbecome 1.8266138
Ġa 0.09565223
Ġblockbuster 0.26499695
Ġdrug 0.617949
, 0.31577593
Ġthere 2.1176944
Ġare 0.104077466
Ġsignificant 3.2237887
Ġhurdles 0.89694273
Ġthat 1.2261708
ĠBritish 3.0888124
ĠBi 0.0026741147
otech 0.0011186653
Ġplc 0.93458205
Ġwill 2.1384082
Ġhave 1.3273511
Ġto 0.0010498388
Ġovercome 0.17152198
. 2.7645948
ĠFirstly 4.9375286
, 0.002220557
Ġthe 0.88221014
Ġdrug 0.53239286
's 2.2426333
Ġpatent 4.6764207
Ġprotection 0.6795764
Ġhas 2.8905044
Ġexpired 0.42709565
, 0.992373
Ġwhich 1.137833
Ġmeans 1.1270713
Ġthat 0.4845371
Ġthe 3.3902025
Ġdrug 0.93595463
Ġis 2.0882282
Ġnow 1.8044208
Ġavailable 0.5591626
Ġas 5.865442
Ġa 0.25245425
Ġgeneric 0.1461295
Ġdrug 0.86159617
. 0.51109177
ĠThis 1.842115
Ġwill 2.1857595
Ġmake 2.262742
Ġit 0.4694635
Ġdifficult 1.765137
Ġfor 0.12245817
ĠBritish 0.5859655
ĠBi 0.002382665
otech 0.0006067679
Ġplc 0.07447514
Ġto 0.01946699
Ġgenerate 2.6220407
Ġsignificant 1.6455688
Ġrevenue 0.65691197
Ġfrom 0.38057727
Ġthe 0.7043542
Ġdrug 0.6583033
.Ċ 2.6160345
Second 1.0797231
ly 0.012484226
, 0.00044961896
Ġthe 0.9487292
Ġcompany 3.1773818
Ġwill 1.2789036
Ġneed 1.3917782
Ġto 0.05454358
Ġdemonstrate 2.9668508
Ġthe 1.2872155
Ġdrug 0.5228978
's 0.019188477
Ġsafety 1.545636
Ġand 0.21778984
Ġefficacy 0.2607599
Ġthrough 3.8434205
Ġfurther 2.666758
Ġclinical 0.2766552
Ġtrials 0.09573511
. 0.75027895
ĠWhile 4.062809
Ġthe 0.8206767
Ġresults 2.1306343
Ġfrom 0.88429147
Ġthe 0.3718982
ĠPhase 0.4392205
ĠIII 0.05727924
Ġclinical 0.6688697
Ġtrial 0.08228246
Ġare 1.4738294
Ġpromising 0.67375445
, 0.029780574
Ġthey 2.036326
Ġwill 2.7144527
Ġneed 0.9802333
Ġto 0.031565458
Ġbe 0.05693089
Ġreplicated 0.97025836
Ġin 0.4291236
Ġlarger 1.7317774
-scale 3.388856
Ġtrials 1.3461957
Ġto 1.3829664
Ġensure 2.3526232
Ġthat 0.86435294
Ġthe 0.6262779
Ġdrug 0.09548495
Ġis 0.9911033
Ġsafe 0.9610908
Ġand 0.31126046
Ġeffective 0.23578832
Ġfor 1.9259369
Ġa 3.3981915
Ġwider 1.3703533
Ġrange 0.87316364
Ġof 0.000996487
Ġpatients 0.63282055
.Ċ 0.9774178
Third 1.9064273
ly 0.0086245015
, 0.000892048
ĠMar 2.245018
im 0.00011915887
ast 0.0005803157
at 0.0002676536
Ġfaces 2.444034
Ġcompetition 1.9133846
Ġfrom 0.15153871
Ġother 1.1202266
ĠMMP 0.9140794
Ġinhibitors 0.22759102
Ġcurrently 3.3885264
Ġin 1.5226382
Ġdevelopment 1.0885066
. 0.3468265
ĠSeveral 4.053853
Ġother 1.688819
Ġpharmaceutical 3.3633308
Ġcompanies 0.0417567
Ġare 0.3689341
Ġdeveloping 1.5106969
ĠMMP 1.0380174
Ġinhibitors 0.1335452
Ġto 2.8911176
Ġtarget 2.719129
Ġcancer 2.787784
, 1.9038193
Ġsuch 2.0491133
Ġas 0.00091122516
ĠGl 5.3859897
ax 0.09821142
o 0.027424013
Smith 0.014738179
K 0.0034051363
line 0.002367086
Ġplc 0.43448702
's 1.5555469
ĠB 3.837947
MS 1.2065938
- 0.1267224
275 6.417877
291 7.3032937
Ġand 1.2110443
ĠMillennium 5.3141212
ĠPharmaceuticals 0.16308574
ĠInc 1.5814793
.' 0.22116151
s 0.00064178446
Ġ( 4.7383842
now 4.071531
ĠT 5.42369
aked 0.114605084
a 0.00027706707
ĠPharmaceutical 0.5369617
ĠCo 0.7641793
. 1.1326008
ĠLtd 0.026700828
.) 0.86448836
ĠPr 8.661655
in 4.7495522
om 1.545991
ast 0.00048179293
at 0.003188167
. 0.42605573
ĠThis 4.549601
Ġmeans 2.2117908
Ġthat 0.059320427
ĠBritish 0.64968926
ĠBi 0.00063368597
otech 0.00074375677
Ġplc 0.031643305
Ġwill 0.47243226
Ġneed 0.93801475
Ġto 0.019588219
Ġwork 3.422766
Ġhard 1.272386
Ġto 0.08264098
Ġdifferentiate 1.5211835
ĠMar 2.1676714
im 6.098748e-05
ast 0.00047523674
at 0.00035572314
Ġfrom 0.23551677
Ġits 1.2675998
Ġcompetitors 0.3435025
Ġand 1.9343107
Ġposition 4.9674416
Ġit 1.7137308
Ġas 0.15970623
Ġthe 1.2610188
Ġmost 3.2069898
Ġeffective 0.68571043
ĠMMP 0.9373117
Ġinhibitor 0.03129572
.Ċ 2.141252
British 2.3246093
ĠBi 0.0012407061
otech 0.0008891871
Ġplc 0.037772108
Ġwill 3.7576938
Ġneed 2.0217643
Ġto 0.021309936
Ġinvest 4.374163
Ġin 1.5273257
Ġmarketing 3.648458
Ġand 0.6286258
Ġresearch 3.9031892
Ġand 0.8651908
Ġdevelopment 0.004609438
Ġto 0.87711024
Ġensure 1.4320456
Ġthat 0.22055855
ĠMar 0.9172615
im 3.106736e-05
ast 0.00039039674
at 0.0001724319
Ġbecomes 1.3177054
Ġa 0.10953738
Ġblockbuster 0.22480357
Ġdrug 0.09283804
. 0.27460402
ĠThe 1.1159863
Ġcompany 0.24189217
Ġwill 0.9435243
Ġneed 1.7788954
Ġto 0.025389764
Ġconduct 3.9846065
Ġfurther 2.0777164
Ġtrials 2.7723002
Ġto 0.4917283
Ġdemonstrate 1.4519341
Ġthe 0.7247344
Ġdrug 0.11170106
's 0.0045409617
Ġsafety 0.61686337
Ġand 0.04015063
Ġefficacy 0.09660589
Ġand 2.1796439
Ġto 1.598515
Ġdetermine 3.5367444
Ġthe 1.4896849
Ġoptimal 1.2476727
Ġdose 1.222132
Ġand 1.761293
Ġtreatment 2.6423132
Ġfor 7.260504
Ġeach 1.8909289
Ġcancer 3.0070102
Ġtype 1.7350848
. 0.4642151
ĠAdditionally 3.294914
, 0.0006781232
Ġthe 0.8377322
Ġcompany 0.07032519
Ġwill 0.12065565
Ġneed 0.18681917
Ġto 0.0065123867
Ġdevelop 2.3313992
Ġstrong 5.3432875
Ġpartnerships 1.257659
Ġwith 0.1314251
Ġphysicians 4.2646556
, 2.326171
Ġhospitals 1.2376688
, 0.06569958
Ġand 0.08412979
Ġother 1.1961889
Ġstakeholders 4.0981812
Ġto 0.4382698
Ġensure 0.90718496
Ġthat 0.16211946
ĠMar 0.7963384
im 2.3915141e-05
ast 0.00027778227
at 0.00018565984
Ġis 1.1902899
Ġwidely 1.072571
Ġprescribed 3.7033575
Ġand 1.7782143
Ġused 1.5749146
Ġin 2.2557735
Ġthe 1.2045392
Ġtreatment 1.385998
Ġof 0.010382989
Ġcancer 0.33673176
.Ċ 0.62621194
Despite 3.4980626
Ġthe 1.1466656
Ġchallenges 1.0018964
, 1.5737333
ĠMar 2.5570626
im 0.00019388489
ast 0.0003498858
at 0.00015359772
's 1.974032
Ġpotential 0.8116874
Ġto 0.9593098
Ġbecome 0.12328386
Ġa 0.019269394
Ġblockbuster 0.01841026
Ġdrug 0.022046378
Ġis 0.96846735
Ġsignificant 2.0498679
. 0.34373945
ĠThe 1.1983134
Ġdrug 0.29664198
Ġhas 1.073973
Ġdemonstrated 3.127994
Ġpromising 0.9110458
Ġresults 0.16034274
Ġin 0.17689544
ĠPhase 1.8146265
ĠIII 0.058017544
Ġclinical 0.09830889
Ġtrials 0.02079342
Ġand 1.1014608
Ġhas 1.2584656
Ġthe 0.8044528
Ġpotential 0.020382231
Ġto 0.0052626953
Ġbecome 0.78934366
Ġa 0.29297906
Ġvaluable 4.240096
Ġtherapeutic 1.964065
Ġoption 0.124764875
Ġfor 0.0476733
Ġcancer 0.6128466
Ġpatients 0.006586051
. 0.42621297
ĠBritish 1.3567086
ĠBi 0.00061319396
otech 0.0019148343
Ġplc 0.013966629
Ġmust 4.6949105
Ġwork 1.7345033
Ġhard 0.22863412
Ġto 0.024512708
Ġovercome 1.4755858
Ġthe 0.7209777
Ġhurdles 1.0370235
Ġand 2.1221924
Ġposition 4.0287313
ĠMar 0.44143802
im 2.1411865e-05
ast 0.00031687375
at 0.00021796036
Ġas 0.044425655
Ġthe 0.30741364
Ġmost 0.33623797
Ġeffective 0.052841898
ĠMMP 0.12416795
Ġinhibitor 0.012649149
Ġon 2.892058
Ġthe 0.0038193145
Ġmarket 0.010703374
. 1.6895796
ĠWith 4.6401553
Ġthe 1.255148
Ġright 1.2890648
Ġinvestment 2.6170979
Ġand 1.0233703
Ġstrategy 4.1996555
, 0.0695909
ĠMar 1.9791605
im 0.00011868205
ast 0.00030209616
at 0.0001375089
Ġcould 0.6405947
Ġbecome 0.44671813
Ġa 0.24858938
Ġkey 5.0734997
Ġplayer 1.4842722
Ġin 0.037241403
Ġthe 0.05149789
Ġfight 2.3298693
Ġagainst 0.010692874
Ġcancer 0.04087824
. 2.0020602
